非侵襲的肝線維化指標と心不全死亡率との関連
Selim Aydemir1, Sidar Şiyar Aydin2, Onur Altinkaya1
1Department of Cardiology, University of Health Sciences, Erzurum City Hospital, Erzurum, Turkey.
Medicine
|January 21, 2026
まとめ
非侵襲的肝線維化指標であるAPRIおよびFIB-4は、心不全(HF)の死亡率を予測する。FIB-4スコアは、すべてのタイプのHFにおける死亡率予測においてAPRIよりも優れており、予後予測に役立つ。
科学分野:
- 循環器病学
- 肝臓病学
- 医学的予後予測
背景:
- 心不全(HF)は罹患率および死亡率の増大原因である。
- HF患者における肝線維症は不良な転帰と相関する。
- HF死亡率の予測ツールは患者管理に不可欠である。
研究 の 目的:
- 非侵襲的肝線維化指標と心不全死亡率との関連を評価する。
- HF死亡率に対するAPRIおよびFIB-4スコアの予測性能を比較する。
主な方法:
- 2029名のHF患者(2017-2024年)の後ろ向き解析。
- 肝線維化指標の計算:AST/ALT比、APRI、およびFIB-4。
- Cox回帰およびROC曲線分析により死亡率予測因子を特定した。
主要な成果:
- APRIおよびFIB-4指数はHFの死亡率を独立して予測した。
- FIB-4スコアはAPRIと比較して優れた予測能力を示した。
- AST/ALT比はHFの死亡率の有意な予測因子ではなかった。
結論:
- FIB-4およびAPRIは、HF死亡率予測のための価値があり、容易に計算可能な非侵襲的マーカーである。
- これらの指標は、HFのフォローアップおよび予後推定に役立つ。
- FIB-4はすべてのタイプのHFにおける死亡率と関連している。APRIはHFrEFおよびHFmrEFにおける死亡率を予測する。
関連する概念動画
Heart Failure II: Pathophysiology
783
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
783
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction
723
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723
Heart Failure VI: Adjunct Therapies
277
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
277
Heart Failure Drugs: Diuretics
824
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
824
Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227


